Navigation Links
Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock
Date:12/22/2011

SAN DIEGO, Dec. 22, 2011 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced the completion of its public offering of 5,646,173 units.  Each unit consisted of one share of common stock and a warrant to purchase ten shares of common stock, at a price to the public of $1.45 per share of common stock and $1.449 per warrant to purchase each share of common stock, which together comprised the purchase price of $15.94 per unit.   Net proceeds, after underwriting discounts and commissions and estimated expenses, were approximately $86.9 million.  The underwriter does not have an option to purchase any additional units in this offering. Leerink Swann LLC acted as sole manager for the offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on September 17, 2009.  The offering was made only by means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained from Leerink Swann LLC , Attention: Syndicate Department, One Federal Street, 37th Fl., Boston, MA 02110 or by calling Leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Orexigen® Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave® has completed Phase 3 clinical trials, and the Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.

 

 

 


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
2. Orexigen® Therapeutics Presents Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
3. Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
4. Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA
5. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
6. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
7. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
8. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
11. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data Solutions ... new website design . The main website, along with ... the company,s new services and content relevant to the ... new streamlined design, viewers can now better understand how ... care practices and create a more visible platform about ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... shareholders held in Hong Kong today. ... proposed by the Company: 1. THAT ...
... Masimo (NASDAQ: MASI ) announced today that ... October 1, 2011, after the market closes on October 25, 2011. ... p.m. PT (4:30 p.m. ET) and will be hosted by Joe ... Executive Vice President and Chief Financial Officer. A live ...
Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
(Date:8/30/2014)... 31, 2014 Fast hosting is ... Top10BestSEOHosting.com has recently compared many professional web hosting ... ) and Arvixe are the suppliers of fastest ... to find a good fast hosting supplier. Actually, ... features, uptime, server speed and customer support. People ...
(Date:8/30/2014)... August 30, 2014 Information supplied by ... to introduce better prices to consumers in 2014. A ... be found when using the open system for adults ... system available to use this year can help the ... on general location and not from medical histories. The ...
(Date:8/30/2014)... Daily Gossip reveals in its review a program created by ... shows a unique formula to get inside a man’s mind ... the program goes beyond mere attraction and actually helps ladies ... that the program was created by dating expert Alex Carter, ... make a man feel emotionally addicted. , Learn more about ...
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... combination of Nutrition and Pharameuticals. Nutraceuticals is a ... extracting healthy ingredients from natural food sources. Nutraceutical ... health benefits to the human body. Nutraceutical health ... diet supplements, fortified foods and more. Although nature ...
(Date:8/30/2014)... After offering hyperbaric oxygen therapy treatments ... several years, Dr. Roy Schmidt and the staff ... scholarship program for veterans who have been diagnosed ... this summer to discuss veterans’ needs ( http://www.prweb.com/releases/2014/06/prweb11954058.htm ... light on the large number of veterans who ...
Breaking Medicine News(10 mins):Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2
... Houston - The University of Texas MD Anderson Cancer Center ... Academy of Sciences (NAS) - one of the most prestigious ... science and engineering. DePinho is the first member of ... The NAS is a private, nonprofit society of ...
... Cone beam CT is superior to mutidetector CT for detecting superior ... hole in the bony wall of the inner ear bone that ... radiation dose, a new study shows. , The study, conducted in ... CT and a multidetector CT examination of their right and left ...
... Over the past decade, there has been a steady ... oil capsules. According to Dr. Louise Moist, a Scientist ... improve outcomes for kidney patients undergoing hemodialysis. ... vessels created to join an artery to a vein. ...
... School of Medicine have gained insight into the mechanism ... to the progression of Alzheimer,s disease (AD) and other ... issue of the Journal of Biological Chemistry, ... to prevent tau from damaging brain circuits involved in ...
... May 1 (HealthDay News) -- A combination of moderate exercise ... risk of age-related memory loss more than computer use or ... in the May issue of Mayo Clinic Proceedings , ... 70 to 93, who completed questionnaires about their computer use ...
... the signaling pathways active in sarcomas, researchers at Moffitt ... a family of protein enzymes that act as "on" ... The tyrosine kinases they identified, the researchers said, could ... sarcomas. Sarcomas are relatively rare forms of cancer. ...
Cached Medicine News:Health News:UT MD Anderson President Ronald DePinho elected to National Academy of Sciences 2Health News:Everyday fish oil capsule may provide kidney-related benefits 2Health News:Researchers gain better understanding of mechanism behind tau spreading in the brain 2Health News:Exercise Plus Computer Time May Boost Seniors' Brains 2Health News:Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival 2
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Endotracheal Tube - Soft red rubber. Silkolatex™ coated. Silkolatex™ cuff. Magill tip - oral. Graduated. X-ray opaque....
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. St...
Medicine Products: